Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000357097-15-000108
Filing Date
2015-11-13
Accepted
2015-11-13 16:36:17
Documents
1
Period of Report
2015-11-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_144745056722234.html 4  
1 FORM 4 wf-form4_144745056722234.xml 4 3042
  Complete submission text file 0000357097-15-000108.txt   4664
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Issuer) CIK: 0000357097 (see all company filings)

EIN.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address
Pernock David (Reporting) CIK: 0001471956 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31564 | Film No.: 151229632